Pulmonary surfactant is a mixture of phospholipids (including disatura
ted phospholipids), cholesterol and proteins lining the air-liquid int
erface within the lung. Surfactant acts to reduce surface tension, the
reby increasing lung compliance and also preventing edema. The saccula
r lungs, or other gas-holding structures, of nonmammals have 7-70% mor
e surfactant/cm(2) of surface than lungs of mammals. Nonmammalian surf
actant acts as an antiglue that decreases the inflation pressures of c
ollapsed lungs by reducing the adherence of apposing epithelial surfac
es. The autonomic nervous system appears to be the primary system cont
rolling release of surfactant in nonmammals. The lipid composition is
highly conserved within the vertebrates, except that surfactant of tel
eost fish is dominated by cholesterol whereas tetrapod surfactant cons
ists primarily of disaturated phospholipids (DSP), The dipnoan Neocera
todus forsteri demonstrates a ''fish-type'' surfactant profile while t
he other derived dipnoans demonstrate a surfactant profile similar to
that of tetrapods, Homology of the surfactant protein SP-A within the
vertebrates points to a single evolutionary origin for the system and
indicates that fish surfactant is a ''protosurfactant''. Amongst the t
etrapods, the relative proportions of DSP and cholesterol vary in resp
onse to lung structure, habitat, and body temperature (T-b) but not in
relation to phylogeny, The cholesterol content of surfactant is eleva
ted in species with simple saccular lungs, in aquatic species, and in
species with low T-b, The DSP content is highest in complex lungs, par
ticularly of aquatic species or species with high T-b, The cholesterol
content of surfactant also increases in response to acute decreases i
n T-b in lizards and torpid marsupials, presumably to maintain fluidit
y of the lipid mixture.